Amylyx Pharmaceuticals, Inc. (AMLX) stock analysis

AMLX · Amylyx Pharmaceuticals, Inc.

Latest recorded price: USD 27.80

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

Fiscal 2025 figures: revenue growth -100.0%. The model flags 3 risk signals for this company (2 high severity).

Similar companies in Healthcare